Aaron Ginsburg
Aaron counsels leading technology companies and venture capital investors on corporate matters across cutting-edge sectors including AI, fintech, digital health, blockchain, gaming, cybersecurity, data analytics, enterprise SaaS, and sports and entertainment. He has extensive experience representing technology companies—from early-stage startups to unicorns—in venture and growth financings, mergers and acquisitions, debt financings, corporate restructurings and other strategic transactions and day-to-day corporate matters.
With an emphasis on strategic partnerships and long-term growth, Aaron leverages his deep industry knowledge and expertise in navigating complex, high stakes deals to provide clients with tailored, forward-thinking legal strategies that drive successful outcomes. Clients appreciate Aaron’s business-focused approach, which allows him to develop practical, commercially driven solutions aligned with their business objectives.
- Multiple financings for Metropolis, including its $1.7B financing for its acquisition of SP Plus Corporation (Nasdaq: SP), $1.1B Term Loan, and $500M Series D financing
- Multiple financings for Machina Labs, including its $16.3M Series A, $32M Series B, and $124M Series C financings
- Multiple financings for Hebbia, including its $30M Series A and $130M Series B financings
- Databricks in its $1B Series K financing
- Ironclad in its $150M Series E financing
- UpGuard in over $100M in multiple rounds of venture financing
- Fun in its $72M Series A financing
- Arbital Health in its $31M Series B financing
- Kontakt.io in its $47.4M Series C financing
- Multiple investments for Lightspeed Ventures, including Anthropic's $3.5B Series E and $13B Series F, Unconventional’s $475M Series Seed, Nexthop AI’s $110M Series A and $500M Series B, Vestwell’s $125M Series D, and Castilion’s $70M Series A and $350M Series B financings
- Multiple investments for other leading venture capital firms, including a16z, Lux Capital, Menlo Ventures, Alpha Edison and Bonfire Ventures
- Multiple investments for corporate investors, including Merck Global Innovation Fund’s investment in N-Power Medicine’s Series B financing
